美国 · 股市与财经 · Bloomberg

Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion

来源：Bloomberg · 美国 2 小时前

Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences, in a deal worth as much as $7.8 billion.

在 Bloomberg 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.bloomberg.com)

推荐阅读

Trump’s Threat to Ban Diesel Exports Sets Off Global Alarms

Billionaire George Soros has donated $102 million ahead of the midterms—and now the Democrats are coming out ahead

ConocoPhillips Signs 20-Year LNG Deal With Venture Global

U.S. to send third carrier group to Mideast as Trump warns of new Iran strikes

Here’s what happened in crypto today

Business Insider

Milk Bar founder Christina Tosi shares the hiring approach she used to grow her bakery business